AGP Executive Report

Last update: 12 hours ago

AI in Medicine: AstraZeneca and Roche Diagnostics will expand AI-powered digital pathology and biomarker testing for breast and lung cancer across nine Asian markets, aiming to improve HER2 and TROP2 assessment and better match patients to targeted therapies. Primary Care Funding: Harvard, Tufts, Boston University and others argue in JAMA for a “primary care common fund,” treating primary care like a public utility so states can pool existing payer spending and pay practices directly. Long COVID Tracking: A Mass General Brigham-led study using an AI tool estimates long COVID at ~16% of COVID patients—about twice current coding-based estimates—suggesting millions may be missed. Gut Regeneration Research: MIT researchers report that the amino acid cysteine can trigger a gut-stem-cell regeneration response after chemotherapy or radiation-like damage, pointing to new ways to protect intestinal lining. Massachusetts Tech & Policy: Massachusetts’ governor’s race pitch drew heavy Trump-linked framing in a Democratic convention speech, while New Hampshire’s proof-of-citizenship voter registration law was struck down by a federal judge. Local Tech & Safety: Manchester, N.H. is moving to add new PTZ school security cameras using state grant funding. Health Tech Business: Boston-based Fifth Down Capital hired former Patriots coach Jerod Mayo as a managing director. Cybercrime Warning: A World Cup fraud report warns scammers are selling fake tickets and “dreams” online as the tournament nears. Marine Science: The New England Aquarium spotted 222 humpback whales east of Cape Cod in an aerial survey.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
May 29, 2026

Influential Women spotlights Charles River scientist Meenakshi Agarwal

EIN Presswire

fallback image
May 28, 2026

Massachusetts Senate backs Dakota’s Law for retired K9 care

EIN Presswire

fallback image
May 29, 2026

XtalPi pushes AI-driven R&D into autonomous experimentation

EIN Presswire

fallback image
May 29, 2026

Integrated autonomous lab platforms reshape research workflows

EIN Presswire


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Massachusetts leaping deeper into quantum technology

Massachusetts leaping deeper into quantum technology

Science news this week: Exploding rocket overshadows NASA's next steps to the moon, 'Doomsday Glacier' faces big loss, quantum computer AI hybrid shows impressive results, and war deepens Iran's water crisis

Science news this week: Exploding rocket overshadows NASA's next steps to the moon, 'Doomsday Glacier' faces big loss, quantum computer AI hybrid shows impressive results, and war deepens Iran's water crisis

Boston Scientific (BSX) Valuation Reset After Watchman Growth Concerns And Intensifying Competition

Boston Scientific (BSX) Valuation Reset After Watchman Growth Concerns And Intensifying Competition

Boston Scientific Corporation (BSX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Boston Scientific Corporation (BSX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Bite me — What it's like to be the human in mosquito research

Bite me — What it's like to be the human in mosquito research

Cleveland Guardians and Boston Red Sox meet in game 2 of series

Cleveland Guardians and Boston Red Sox meet in game 2 of series


fallback image
May 29, 2026

Imviva Biotech to Present Data from Clinical Studies of CTA313 and CTD402 Validating its ANSWER™ Allogeneic CAR-T Platform in Pediatric and Adult Patient Populations at EULAR and EHA 2026 Congresses

GlobeNewswire, Inc.

fallback image
May 29, 2026

Sparrow Pharmaceuticals to Present Phase 2a Results for Clofutriben in Type 2 Diabetes at the 2026 American Diabetes Association (ADA) Scientific Session

GlobeNewswire, Inc.

fallback image
May 29, 2026

Influential Women Spotlights Meenakshi Agarwal: Research Scientist I at Charles River Laboratories

EIN Presswire

fallback image
May 29, 2026

PPHC to Participate in Stifel’s Ninth Annual Boston Cross Sector 1x1 Conference

GlobeNewswire, Inc.

fallback image
May 28, 2026

Massachusetts K9 Heroes One Step Closer to Protection After Historic Senate Vote on Dakota’s Law

EIN Presswire

fallback image
May 29, 2026

XtalPi: Defining the Next-Generation R&D Paradigm Through AI for Science

EIN Presswire

More press releases

Video Stories

YouTube video thumbnail: Conan O’Brien Jokes About 'too Many Foreign Students' as Trump Tightens Pressure on Harvard
Play
Conan O’Brien Jokes About 'too Many Foreign Students' as Trump Tightens Pressure on Harvard
YouTube video thumbnail: Trump on a $250 Bill? US Treasury Pushes for First Banknote Featuring a Living President
Play
Trump on a $250 Bill? US Treasury Pushes for First Banknote Featuring a Living President
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: How the U.S. is Preparing for the World Cup's Security Challenges Like Drones and Terrorism
Play
How the U.S. is Preparing for the World Cup's Security Challenges Like Drones and Terrorism
YouTube video thumbnail: Some U.S. States Stand Against AI Data Centers
Play
Some U.S. States Stand Against AI Data Centers

Video Title

Sign up for:

Boston Technology Review

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Sign up for:

Boston Technology Review

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.